1-3-(4-Fluorobenzoyl)propyl-4-substituted phenoxy ethyl piperazine
US3966735A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Mar 5, 1974 |
| Grant date | Jun 29, 1976 |
| Priority date | — |
| Expiry date | Mar 5, 1994 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/108
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Piperazine derivatives having the following general formula ##EQU1## in which n is 2 or 3, X is an oxy or thio radical, and A and B are each a radical of the group consisting of phenyl radicals containing at most three substituents of the group consisting of nitro, trifluoromethyl, halogen, cyano, and alkyl, alkoxy, alkylthio, acyl, and alkylsulfonyl radicals containing at most 6 carbon atoms, and similar cycloalkyl and cycloalkylalkyl radicals, their acid addition salts, processes for their production, and pharmaceutical compositions containing the same. The compounds have a very favorable action on the central nervous system and are effective agents for the treatment of anxiety states, psychoses, emotional disturbances, aggressive tendencies, and can be used generally for the treatment of psychiatrically disturbed and psychoneurotic patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.